Clinical trial
Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy…
NCT00191256 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191256 |
|---|---|
| Title | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer |
| Official title | Randomized Phase II Trial to Outline the Efficacy of Gemcitabine Containing Regimens (Gemcitabine/Carboplatin and Gemcitabine/Paclitaxel) When Used as Preoperative Chemotherapy In Patients With Stage I and II NSCLC |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non Small Cell Lung |
| Intervention type | Drug |
| Interventions | Gemcitabine, Carboplatin, Paclitaxel |
| Enrollment | 77 |
| Start date | Jun 1, 2001 |
| Completion | Jul 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: